Price
1D
5D
1M
6M
YTD
1Y
5Y
▤ Line ▾
⏱ 2m ▾
∿ Studies 0 ▾
⇄ Compare ▾
✎ Draw 0 ▾
EXT
%
LOG
⟲
⛶
Chart style ✕
Chart style
Line Area
Candles OHLC bars
Interval ✕
Interval
1 min 2 min
5 min 15 min
30 min 1 hour
1 day 1 week
Intraday intervals only cover recent history. The site picks the finest interval the range allows.
Studies ✕
Overlays
SMA 20 SMA 50
SMA 200 EMA 21
Bollinger VWAP
Session levels
Prior day H/L/C
Opening range
Volume profile
Lower pane
Volume
RSI 14 MACD
Compare ✕
Overlay another symbol
SPY QQQ
IWM DIA
Add
Remove comparison
Both series are rebased to 0% at the left edge, so the lines show relative performance rather than price.
Drawing tools ✕
Tool
Cursor Trend line
Price level Zone
Measure
Clear all drawings
1D
—
H —
L —
Range —
Vol —
vs
Drag pan · Pinch zoom · Hold crosshair · pick a tool then drag to draw
Trailing performance Price return · vs SPY
Return vs SPY
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Free account
3 more panels on MRK.SN open with an account.
Options chains and analytics, valuation ratios, insider filings, analyst targets and ownership. No card, no trial, nothing to cancel.
Fundamentals TTM · reported
Market cap —
Enterprise value —
Revenue (TTM) —
Gross profit —
EBITDA —
Net income —
EPS (TTM) —
Free cash flow —
Total cash —
Total debt —
Book value / share —
Shares outstanding —
Float —
Short % of float —
Dividend yield —
Beta (5Y) —
Valuation & profitability ratios Account required
Trailing P/E —
Forward P/E —
PEG ratio —
Price / sales —
Price / book —
EV / revenue —
EV / EBITDA —
Gross margin —
Operating margin —
Profit margin —
Return on equity —
Return on assets —
Debt / equity —
Current ratio —
Free account required
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Financial statements As reported · 4 years · 6 quarters
Income Balance sheet Cash flow
Annual Quarterly
Blank means not reported, not zero
Line item 2025 2024 2023 2022 YoY
Total revenue
$65.01B $64.17B $60.12B $59.28B
+1.3%
Operating revenue
$65.01B $64.17B $60.12B $59.28B
+1.3%
Cost of revenue
$16.38B $15.19B $16.13B $17.41B
+7.8%
Gross profit
$48.63B $48.98B $43.99B $41.87B
-0.7%
Research & development
$15.79B $17.94B $30.53B $13.55B
-12.0%
Selling, general & admin
$10.73B $10.82B $10.50B $10.04B
-0.8%
Total operating expense
$26.52B $28.75B $41.03B $23.59B
-7.8%
Operating income
$22.11B $20.22B $2.95B $18.28B
+9.3%
Net interest income
-$1.01B -$856.00M -$781.00M -$805.00M
-18.5%
Pre-tax income
$21.07B $19.94B $1.89B $16.44B
+5.7%
Tax provision
$2.80B $2.80B $1.51B $1.92B
+0.0%
Net income
$18.25B $17.12B $365.00M $14.52B
+6.6%
Net income to common
$18.25B $17.12B $365.00M $14.52B
+6.6%
Basic EPS
7.38 6.77 0.14 5.73
+8.9%
Diluted EPS
7.28 6.74 0.14 5.71
+8.0%
EBIT
$22.42B $21.21B $3.04B $17.41B
+5.7%
EBITDA
$28.26B $25.71B $6.91B $21.32B
+9.9%
Basic shares
2.47B 2.53B 2.61B 2.53B
-2.1%
Diluted shares
2.51B 2.54B 2.61B 2.54B
-1.3%
Line item 2025 2024 2023 2022 YoY
Cash & equivalents
$14.56B $13.24B $6.84B $12.69B
+10.0%
Cash & short-term investments
$14.56B $13.69B $7.09B $13.19B
+6.4%
Accounts receivable
$11.78B $10.28B $10.35B $9.45B
+14.6%
Inventory
$6.66B $6.11B $6.36B $5.91B
+9.0%
Total current assets
$43.52B $38.78B $32.17B $35.72B
+12.2%
Property, plant & equipment
$25.32B $23.78B $23.05B $21.42B
+6.5%
Goodwill & intangibles
$48.26B $38.04B $39.21B $41.47B
+26.9%
Total assets
$136.87B $117.11B $106.67B $109.16B
+16.9%
Total current liabilities
$28.33B $28.42B $25.69B $24.24B
-0.3%
Current debt
$2.59B $2.65B $1.37B $1.95B
-2.3%
Long-term debt
$46.75B $34.46B $33.68B $28.75B
+35.7%
Total debt
$49.34B $37.11B $35.05B $30.69B
+32.9%
Total liabilities
$84.20B $70.73B $69.04B $63.10B
+19.0%
Retained earnings
$73.08B $63.07B $53.90B $61.08B
+15.9%
Shareholder equity
$52.61B $46.31B $37.58B $45.99B
+13.6%
Working capital
$15.19B $10.36B $6.47B $11.48B
+46.6%
Net tangible assets
$4.35B $8.28B -$1.63B $4.52B
-47.5%
Shares issued
3.58B 3.58B 3.58B 3.58B
0.0%
Line item 2025 2024 2023 2022 YoY
Net income
$18.26B $17.13B $377.00M $14.53B
+6.6%
Depreciation & amortisation
$5.84B $4.50B $3.87B $3.91B
+29.8%
Stock-based compensation
$820.00M $761.00M $645.00M $541.00M
+7.8%
Change in working capital
-$6.98B -$3.67B -$2.21B -$2.78B
-90.2%
Operating cash flow
$16.47B $21.47B $13.01B $19.09B
-23.3%
Capital expenditure
-$4.11B -$3.37B -$3.86B -$4.39B
-21.9%
Investing cash flow
-$13.74B -$7.73B -$14.08B -$4.96B
-77.7%
Share buybacks
-$5.08B -$1.31B -$1.35B $0
-289.3%
Dividends paid
-$8.18B -$7.84B -$7.45B -$7.01B
-4.3%
Financing cash flow
-$1.92B -$7.03B -$4.81B -$9.12B
+72.7%
Free cash flow
$12.36B $18.10B $9.14B $14.71B
-31.7%
End cash position
$14.69B $13.32B $6.91B $12.77B
+10.3%
Line item 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 YoY
Total revenue
$16.61B $16.29B $16.40B $17.28B $15.81B —
+2.0%
Operating revenue
$16.61B $16.29B $16.40B $17.28B $15.81B —
+2.0%
Cost of revenue
$4.39B $4.20B $5.55B $3.85B $3.56B —
+4.8%
Gross profit
$12.21B $12.09B $10.85B $13.42B $12.25B —
+1.0%
Research & development
$9.74B $12.59B $3.89B $4.23B $4.05B —
-22.6%
Selling, general & admin
$2.90B $2.70B $2.90B $2.63B $2.65B —
+7.6%
Total operating expense
$12.64B $15.29B $6.78B $6.87B $6.70B —
-17.3%
Operating income
-$433.00M -$3.20B $4.07B $6.55B $5.55B —
+86.5%
Net interest income
-$490.00M -$444.00M -$342.00M -$231.00M -$236.00M —
-10.4%
Pre-tax income
-$683.00M -$3.53B $3.42B $6.75B $5.00B —
+80.7%
Tax provision
$654.00M $709.00M $458.00M $958.00M $571.00M —
-7.8%
Net income
-$1.33B -$4.24B $2.96B $5.79B $4.43B —
+68.5%
Net income to common
-$1.33B -$4.24B $2.96B $5.79B $4.43B —
+68.5%
Basic EPS
-0.54 -1.72 1.20 2.33 1.77 —
+68.6%
Diluted EPS
-0.54 -1.72 1.19 — 1.76 2.01
+68.6%
EBIT
-$158.00M -$3.06B $3.83B $7.07B $5.30B —
+94.8%
EBITDA
$1.43B -$1.54B $6.30B $8.23B $6.42B —
+192.4%
Basic shares
2.47B 2.47B 2.47B 2.49B 2.50B —
-0.1%
Diluted shares
2.47B 2.47B 2.49B — 2.51B 2.53B
-0.1%
Line item 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 YoY
Cash & equivalents
$6.85B $5.33B $14.56B $18.17B $8.01B
+28.6%
Cash & short-term investments
$7.14B $5.70B $14.56B $18.21B $8.62B
+25.2%
Accounts receivable
$12.56B $12.21B $11.78B $12.12B $11.85B
+2.9%
Inventory
$6.21B $6.48B $6.66B $6.44B $6.60B
-4.2%
Total current assets
$36.68B $35.02B $43.52B $47.56B $37.06B
+4.8%
Property, plant & equipment
$25.74B $25.43B $25.32B $25.64B $25.24B
+1.2%
Goodwill & intangibles
$46.56B $47.33B $48.26B $36.90B $36.78B
-1.6%
Total assets
$129.80B $128.69B $136.87B $129.55B $117.52B
+0.9%
Total current liabilities
$27.73B $26.95B $28.33B $28.63B $26.04B
+2.9%
Current debt
$2.83B $2.44B $2.59B $1.41B $1.43B
+15.6%
Long-term debt
$51.08B $46.67B $46.75B $39.97B $33.97B
+9.4%
Total debt
$53.91B $49.12B $49.34B $41.37B $35.40B
+9.8%
Total liabilities
$87.82B $82.75B $84.20B $77.64B $68.46B
+6.1%
Retained earnings
$63.27B $66.72B $73.08B $72.23B $68.48B
-5.2%
Shareholder equity
$41.93B $45.88B $52.61B $51.85B $48.99B
-8.6%
Working capital
$8.95B $8.07B $15.19B $18.93B $11.03B
+10.9%
Net tangible assets
-$4.63B -$1.45B $4.35B $14.95B $12.21B
-219.5%
Shares issued
2.47B 3.58B 3.58B 3.58B 3.58B
-31.0%
Line item 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 YoY
Net income
-$1.34B -$4.24B $2.96B $5.79B $4.43B
+68.5%
Depreciation & amortisation
$1.58B $1.51B $2.47B $1.15B $1.12B
+4.7%
Stock-based compensation
$298.00M $185.00M $205.00M $204.00M $216.00M
+61.1%
Change in working capital
$423.00M -$1.61B -$2.32B $1.31B -$2.26B
+126.2%
Operating cash flow
$5.37B $3.92B $2.86B $7.82B $3.29B
+37.1%
Capital expenditure
-$893.00M -$991.00M -$1.03B -$987.00M -$764.00M
+9.9%
Investing cash flow
-$5.60B -$10.21B -$11.20B -$283.00M -$770.00M
+45.1%
Share buybacks
-$757.00M -$874.00M -$1.25B -$1.32B -$1.34B
+13.4%
Dividends paid
-$2.14B -$2.10B -$2.02B -$2.03B -$2.08B
-1.9%
Financing cash flow
$1.76B -$2.98B $4.75B $2.64B -$3.56B
+159.1%
Free cash flow
$4.48B $2.93B $1.82B $6.83B $2.53B
+53.0%
End cash position
$6.89B $5.40B $14.69B $18.26B $8.07B
+27.7%
Analyst targets & ownership Account required
Mean target —
High target —
Low target —
Implied upside —
Analyst count —
Consensus —
Strong buy / Buy — / —
Hold —
Sell / Strong sell — / —
Held by insiders —
Held by institutions —
Institutions holding —
Free account required
Price targets, consensus spread, insider and institutional ownership.
Moving averages & technicals Computed from 2Y daily closes
SMA 10
131.50
+3.40% from price
SMA 20
131.50
0.00% from price
SMA 50
127.45
+3.18% from price
SMA 100
122.58
+10.93% from price
SMA 200
113.71
+15.64% from price
EMA 12
131.44
+3.45% from price
EMA 26
130.51
+4.19% from price
EMA 50
128.00
+6.23% from price
MACD (12,26,9)
0.93
Hist -0.34
Realised vol 30D
6.8%
Annualised
Bollinger upper
131.50
20, 2σ
Bollinger lower
131.50
20, 2σ
50 / 200 cross
Golden
127.45 vs 113.71
Trend bias
Above 200
+15.64%
Options chain Account required
Expiry Loading…
Calls Puts
Spot 135.97
Calls Strike Last Bid Ask Vol OI IV
000.00 0.00 0.00 0.00 0 0 0.0% 000.00 0.00 0.00 0.00 0 0 0.0% 000.00 0.00 0.00 0.00 0 0 0.0% 000.00 0.00 0.00 0.00 0 0 0.0% 000.00 0.00 0.00 0.00 0 0 0.0% 000.00 0.00 0.00 0.00 0 0 0.0% 000.00 0.00 0.00 0.00 0 0 0.0%
Puts Strike Last Bid Ask Vol OI IV
000.00 0.00 0.00 0.00 0 0 0.0% 000.00 0.00 0.00 0.00 0 0 0.0% 000.00 0.00 0.00 0.00 0 0 0.0% 000.00 0.00 0.00 0.00 0 0 0.0% 000.00 0.00 0.00 0.00 0 0 0.0% 000.00 0.00 0.00 0.00 0 0 0.0% 000.00 0.00 0.00 0.00 0 0 0.0%
Free account required
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Risk profile Daily returns · 1Y window
Beta vs SPY
0.00
Less volatile than market
Correlation to SPY
0.00
Largely independent
Realised vol 30D
6.8%
Annualised
Market vol 1Y
12.8%
SPY, annualised
Max drawdown 1Y
-2.2%
Peak to trough
Max drawdown 5Y
-40.5%
Peak to trough
ATR 14
0.00
Average true range
Beta (reported)
—
5Y monthly, from filing
Headlines MRK.SN · links out to the publisher
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.
Request the strategy overview